NexLife vs LillyDirect: prices compared
Released · Last reviewed
LillyDirect sells brand Zepbound, an FDA-approved drug, at $299 (2.5 mg), $399 (5 mg) and $449 (7.5–15 mg when each refill is within 45 days; otherwise $499 at 7.5 mg and $699 at 10–15 mg). NexLife sells compounded tirzepatide, which is not FDA-approved, at $129 a month month-to-month or $115 on a 12-month plan at every dose.
Qualification: NexLife is our featured provider; this page uses the same price rules for both programs, and other tracked programs charge less than NexLife on some plans.
How do NexLife and LillyDirect compare on price?
| Program | Drug | Plan prices | Lowest all-in / mo | Membership | Status · source |
|---|---|---|---|---|---|
| NexLife | semaglutide | 1 mo $109 · 3 mo $105 · 6 mo $99 · 12 mo $95 | $95 | none | Verified, not ranked nexlife.us · 2026-11-06 |
| LillyDirect | semaglutide | Not offered or not tracked | |||
| NexLife | tirzepatide | 1 mo $129 · 3 mo $125 · 6 mo $119 · 12 mo $115 | $115 | none | Verified, not ranked nexlife.us · 2026-11-06 |
| LillyDirect | tirzepatide (brand) | 1 mo $299 | — | none | Provider Reported zepbound.lilly.com · 2026-09-30 |
Which is cheaper: the arithmetic
LillyDirect sells brand Zepbound, an FDA-approved drug, at $299 (2.5 mg), $399 (5 mg) and $449 (7.5–15 mg when each refill is within 45 days; otherwise $499 at 7.5 mg and $699 at 10–15 mg). NexLife sells compounded tirzepatide, which is not FDA-approved, at $129 a month month-to-month or $115 on a 12-month plan at every dose. Over a year at a 10 mg maintenance dose with on-time refills: $449 × 12 = $5,388 for Zepbound against $115 × 12 = $1,380 for NexLife on a 12-month plan.
What does NexLife include?
Same price at every dose, no membership fee, provider review from NexLife Medical Group (medical director Adam Kennah, M.D.), a nutrition plan, a coaching call, 24/7 support and free expedited shipping. Its plan pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA). Lab work is not stated as included. Cancellations take effect after 30 days.
Who might prefer each?
- NexLife fits someone who wants one price at every dose, named pharmacies and support included, and who is comfortable with a 30-day cancellation notice.
- LillyDirect fits someone for whom its price and plan structure in the table above work better; check its plan term, membership and pharmacy disclosure before paying.
Frequently asked questions
Is NexLife or LillyDirect cheaper?
LillyDirect sells brand Zepbound, an FDA-approved drug, at $299 (2.5 mg), $399 (5 mg) and $449 (7.5–15 mg when each refill is within 45 days; otherwise $499 at 7.5 mg and $699 at 10–15 mg). NexLife sells compounded tirzepatide, which is not FDA-approved, at $129 a month month-to-month or $115 on a 12-month plan at every dose.
Is NexLife the cheapest program you track?
Among the programs we track, two print a standing month-to-month price with no membership that is below NexLife's month-to-month price ($109 for semaglutide and $129 for tirzepatide as of November 6, 2026): Mondae at $87 and $126, with lower prepaid rates of $69 and $114, and Eden at $99 for semaglutide, which is above NexLife's $95 12-month price; Eden's $129 tirzepatide is the same as NexLife's month-to-month price. Competitor prices were read on October 15, 2026. Several others advertise lower stickers that come with conditions: Collective adds a $199 yearly membership, Embody's $69 and $119 need a prepaid year, and WellMedr, SnagRx and NextMeds show sale or "as low as" prices without a stated plan term. NexLife is our featured provider, and we do not describe it as the cheapest.
Are these drugs FDA-approved?
Zepbound sold through LillyDirect is FDA-approved. Compounded tirzepatide, including NexLife's, is not FDA-approved and is not a generic Zepbound; FDA does not review compounded drugs for safety, effectiveness or quality before they are sold.
Profiles: NexLife · LillyDirect · all tirzepatide prices